回答: 两种抗凝剂的比较,用于与血小板丰富血注射相关的疼痛
Ertuğrul Karanfil1, Ali Doğan2, Metin Görgü3
1Department of Plastic, Reconstructive and Aesthetic Surgery, Abant Izzet Baysal University, 14280, GölköyBolu, Turkey.
Aesthetic plastic surgery
|September 22, 2023
概括
在富血小板血 (PRP) 制剂中使用的不同抗凝剂显著影响注射疼痛. 需要进一步的研究,以了解PRP治疗中观察到的疼痛变异背后的生理原因.
科学领域:
- 整形外科 整形外科 整形外科
- 再生医学是一种再生医学.
- 疼痛管理 疼痛管理
背景情况:
- 富血小板血 (PRP) 治疗涉及许多影响治疗结果的变量.
- 关键变量包括制备方法,应用技术,注射量和PRP成分 (血小板度,白细胞存在,pH).
- 与PRP注射相关的疼痛是影响患者体验和治疗坚持的关键因素.
研究的目的:
- 为了研究不同抗凝剂对在富血小板血 (PRP) 注射期间出现的疼痛的影响.
- 突出需要进一步研究 PRP 准备过程中疼痛变化的潜在生理机制.
主要方法:
- 这项研究专注于评估在PRP注射过程中经历的疼痛.
- 在使用不同抗凝剂的PRP制剂之间进行了比较.
- 研究的设计旨在确定注射疼痛的差异,而不是这些差异的具体原因.
主要成果:
- 当在PRP制备过程中使用不同的抗凝剂时,观察到疼痛的显著差异.
- 该研究证实,抗凝剂的选择会影响与PRP注射相关的疼痛.
结论:
- 在PRP制剂中使用不同的抗凝剂可能会导致注射相关疼痛的差异.
- 由于不同的抗凝剂,PRP组成的潜在变化可能是观察到的疼痛变化的原因.
- 需要进一步的研究来阐明这些疼痛差异的生理基础和原因.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
552
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
552
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
452
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
452
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
203
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
203


